B · Normal
On September 15th, Gilead Sciences executives stated in a conference call that the growth of the HIV drug market is expected to return to normal levels of 2% to 3% in the next few quarters.
Related telegraphs
On September 23rd, U.S. quantum computing concept stocks all rose in overnight t
09-23 08:13
[Dissatisfied with BHP Billiton’s pay plan, the world’s largest Chilean copper m
09-23 07:49
On September 23, WTI crude oil futures fell by 1% to US$89.61 per barrel.
09-23 07:41
[AI “doomsday theory” refuted by UN experts] According to a report by Agence Fra
09-23 06:52
[Typhoon "Dujuan" has killed 7 people in Japan] September 23rd, the reporter lea
09-23 06:22
[The probability of the Federal Reserve raising interest rates in October is 54.
09-23 06:03
Comments